Maxygen And Astellas Form Joint Venture, Combining Cash And Staff
Three senior execs will depart in a deal that could result in a staged acquisition of the J/V by the Japanese pharma.
Three senior execs will depart in a deal that could result in a staged acquisition of the J/V by the Japanese pharma.